What Is Precision Timed Release (PTR) Technology? A New Way To Treat ADHD

Comments
Loading...

Shane J. Schaffer and Dr. Ann Childress, CEO and consultant at Cingulate Inc. CING, respectively, were guest speakers at Benzinga’s All Access on June 3rd, 2022.

Cingulate is a biopharmaceutical company engaging in the research and development of new product candidates for the treatment of central nervous system disorders - specially its innovative Precision Timed Release (PTR) Technology. 

Watch the full interview here. 

Photo by Mitchell Griest on Unsplash

 

CING Logo
CINGCingulate Inc
$3.65-0.27%

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score
Edge Rankings
Momentum6.89
Growth-
Quality-
Value-
Price Trend
Short
Medium
Long
Market News and Data brought to you by Benzinga APIs

Posted In: